Chih-Cheng Wan1,2, David Yen-Ting Chen1,2, Ying-Chi Tseng1,2, Feng-Xian Yan1, Kun-Yu Lee1,2, Chen-Hua Chiang1,2, Chi-Jen Chen3,4. 1. Department of Radiology, Shuang-Ho Hospital, Taipei Medical University, No. 291, Zhongzheng Rd., Zhonghe District, New Taipei City, 235, Taiwan. 2. School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wu-Hsing Street, Taipei, 110, Taiwan. 3. Department of Radiology, Shuang-Ho Hospital, Taipei Medical University, No. 291, Zhongzheng Rd., Zhonghe District, New Taipei City, 235, Taiwan. ed100975@yahoo.com. 4. School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wu-Hsing Street, Taipei, 110, Taiwan. ed100975@yahoo.com.
Abstract
PURPOSE: No reliable imaging sign predicting cerebral hyperperfusion after intracranial arterial stenting (IAS) had been described in the literature. This study evaluated the effect of fluid-attenuated inversion recovery vascular hyperintensities (FVHs), also called hyperintense vessel sign on T2-weighted fluid-attenuated inversion recovery (T2-FLAIR) MR images, in predicting significant increase in cerebral blood flow (CBF) defined by arterial spin labeling (ASL) after IAS. METHODS: We reviewed ASL CBF images and T2-FLAIR MR images before (D0), 1 day after (D1), and 3 days after (D3) IAS of 16 patients. T1-weighted MR images were used as cerebral maps for calculating CBF. The changes in CBF values after IAS were calculated in and compared among stenting and nonstenting vascular territories. An increase more than 50% of CBF was considered as hyperperfusion. The effect of FVHs in predicting hyperperfusion was calculated. RESULTS: The D1 CBF value was significantly higher than the D0 CBF value in stenting vascular, contralateral anterior cerebral artery, contralateral middle cerebral artery, and contralateral posterior cerebral artery (PCA) territories (all P < .05). The D1 and D3 CBF values were significantly higher than the D0 CBF value in overall vascular (P < .001), overall nonstenting vascular (P < .001), and ipsilateral PCA (P < .05) territories. The rate of more than 50% increases in CBF was significantly higher in patients who exhibited asymmetric FVHs than in those who did not exhibit these findings. CONCLUSION: FVHs could be a critical predictor of a significant increase in CBF after IAS.
PURPOSE: No reliable imaging sign predicting cerebral hyperperfusion after intracranial arterial stenting (IAS) had been described in the literature. This study evaluated the effect of fluid-attenuated inversion recovery vascular hyperintensities (FVHs), also called hyperintense vessel sign on T2-weighted fluid-attenuated inversion recovery (T2-FLAIR) MR images, in predicting significant increase in cerebral blood flow (CBF) defined by arterial spin labeling (ASL) after IAS. METHODS: We reviewed ASL CBF images and T2-FLAIR MR images before (D0), 1 day after (D1), and 3 days after (D3) IAS of 16 patients. T1-weighted MR images were used as cerebral maps for calculating CBF. The changes in CBF values after IAS were calculated in and compared among stenting and nonstenting vascular territories. An increase more than 50% of CBF was considered as hyperperfusion. The effect of FVHs in predicting hyperperfusion was calculated. RESULTS: The D1 CBF value was significantly higher than the D0 CBF value in stenting vascular, contralateral anterior cerebral artery, contralateral middle cerebral artery, and contralateral posterior cerebral artery (PCA) territories (all P < .05). The D1 and D3 CBF values were significantly higher than the D0 CBF value in overall vascular (P < .001), overall nonstenting vascular (P < .001), and ipsilateral PCA (P < .05) territories. The rate of more than 50% increases in CBF was significantly higher in patients who exhibited asymmetric FVHs than in those who did not exhibit these findings. CONCLUSION: FVHs could be a critical predictor of a significant increase in CBF after IAS.
Authors: Walther N K A van Mook; Roger J M W Rennenberg; Geert Willem Schurink; Robert Jan van Oostenbrugge; Werner H Mess; Paul A M Hofman; Peter W de Leeuw Journal: Lancet Neurol Date: 2005-12 Impact factor: 44.182
Authors: Y Uchihashi; K Hosoda; I Zimine; A Fujita; M Fujii; K Sugimura; E Kohmura Journal: AJNR Am J Neuroradiol Date: 2011-07-14 Impact factor: 3.825
Authors: A Kufner; I Galinovic; V Ambrosi; C H Nolte; M Endres; J B Fiebach; M Ebinger Journal: AJNR Am J Neuroradiol Date: 2015-05-14 Impact factor: 3.825
Authors: P M Meyers; R T Higashida; C C Phatouros; A M Malek; T E Lempert; C F Dowd; V V Halbach Journal: Neurosurgery Date: 2000-08 Impact factor: 4.654
Authors: Si Eun Kim; Byung In Lee; Sung Eun Kim; Kyong Jin Shin; JinSe Park; Kang Min Park; Hyung Chan Kim; Joonwon Lee; Hye Jin Baek; Sung-Cheol Jin; Sam Yeol Ha Journal: Stroke Date: 2016-05-05 Impact factor: 7.914